By Lucia Osborne-Crowley ( July 15, 2021, 11:50 AM BST) -- Britain's competition watchdog said Thursday it has fined a group of pharmaceutical companies including U.K. giant Accord a total of £260 million ($360 million) for overcharging the National Health Service for a life-saving adrenal drug by more than 10,000%....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.